Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus.

B cell B cell receptor hepatitis C virus neutralizing antibody vaccine

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 05 04 2023
accepted: 18 04 2023
pubmed: 14 5 2023
medline: 14 5 2023
entrez: 14 5 2023
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fimmu.2023.1135841.].

Identifiants

DOI: 10.3389/fimmu.2023.1201033 PMID: 37180140 PMC: PMC10167485
pubmed: 37180140
doi: 10.3389/fimmu.2023.1201033
pmc: PMC10167485
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1201033

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM136577
Pays : United States

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2023 Skinner, Ogega, Frumento, Clark, Paul, Yegnasubramanian, Schuebel, Meyers, Gupta, Wheelan, Cox, Crowe, Ray and Bailey.

Auteurs

Nicole E Skinner (NE)

Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, United States.
Department of Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.

Clinton O Ogega (CO)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Nicole Frumento (N)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Kaitlyn E Clark (KE)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Harry Paul (H)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Srinivasan Yegnasubramanian (S)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Kornel Schuebel (K)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Jennifer Meyers (J)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Anuj Gupta (A)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Sarah Wheelan (S)

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Andrea L Cox (AL)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

James E Crowe (JE)

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States.
Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, United States.

Stuart C Ray (SC)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Justin R Bailey (JR)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Classifications MeSH